Tumor necrosis factor blockers in rheumatoid arthritis

Article Abstract:

More research is needed before drugs that block tumor necrosis factor can be recommended for the treatment of rheumatoid arthritis. Tumor necrosis factor is an inflammatory protein produced by the body. Because rheumatoid arthritis is partly an inflammatory disease, drugs that inhibit tumor necrosis factor might be useful. A 2000 study shows that an inhibitory drug called etanercept is indeed beneficial in children with juvenile rheumatoid arthritis. The drug has also been tested in adults with similar benefits. However, it is more expensive than traditional arthritis drugs.

Health aspects, Editorial, Enbrel (Medication)

---

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

Article Abstract:

The efficacy and safety of abatacept, a selective costimulation modulator, was assessed in patients with active rheumatoid arthritis and an insufficient response to a minimum of three months of anti tumor necrosis factor alpha (TNF-alpha) treatment. Findings confirmed that patients with insufficient response to anti-TNF-alpha treatment benefited substantially in both clinical and functional aspects.

Science & research, New England States, Research, Tumor necrosis factor, New England, Tumour necrosis factor, Antirheumatic agents

---

Tuberculosis associated witih inflximab, a tumor necrosis factor alpha-neutralizing agent

Article Abstract:

The drug Remicade may cause tuberculosis in patients who take the drug for rheumatoid arthritis or Crohn's disease. Remicade blocks the activity of tumor necrosis factor-alpha, which is an immune system protein. This supports the idea that tumor necrosis factor-alpha may protect people from tuberculosis.

Causes of, Complications and side effects, Tuberculosis, Crohn's disease, Remicade (Medication)

Similar abstracts:

• Abstracts: Smoking, lung function, and rheumatoid factors. Mortality in rheumatoid arthritis patients with disease onset in the 1980s
• Abstracts: Dental hygiene: adding value to your practice. Controlling the numbers that control your life: how monitoring costs can improve your personal, professional life
• Abstracts: Acute myocardial infarction - the value of being prepared. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
• Abstracts: Molecular targets of gene transfer therapy for HIV infection. Strategies for Long-term Success in the Treatment of HIV Infection
• Abstracts: Brief physician advice for problem alcohol drinkers: a randomized controlled trial in community-based primary care practices

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.